Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody Molecule
BOSTON & SOLNA, Sweden--(BUSINESS WIRE)--Mar 20, 2019--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Affibody AB today announced a partnership to co-develop ABY-039 for rare Immu…
